日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Author Correction: Identification of a non-inhibitory aptameric ligand to CRL2(ZYG11B) E3 ligase for targeted protein degradation

作者更正:鉴定一种非抑制性CRL2(ZYG11B) E3连接酶适体配体用于靶向蛋白降解

Yang, Zhihao; Chen, Miao; Ge, Ruixin; Zhou, Ping; Pan, Wei; Song, Jiayi; Ma, Shuwen; Chen, Song; Xu, Chenyu; Zhou, Mengyu; Mi, Wenyi; Ni, Hua; Chen, He; Yao, Xue; Dong, Xifeng; Chen, Yan; Zhou, Jun; Xuan, Chenghao; Dong, Cheng; Yan, Hua; Xie, Songbo

Identification of a non-inhibitory aptameric ligand to CRL2(ZYG11B) E3 ligase for targeted protein degradation.

鉴定一种对 CRL2(ZYG11B) E3 连接酶无抑制作用的适体配体,用于靶向蛋白质降解

Yang Zhihao, Chen Miao, Ge Ruixin, Zhou Ping, Pan Wei, Song Jiayi, Ma Shuwen, Chen Song, Xu Chenyu, Zhou Mengyu, Mi Wenyi, Ni Hua, Chen He, Yao Xue, Dong Xifeng, Chen Yan, Zhou Jun, Xuan Chenghao, Dong Cheng, Yan Hua, Xie Songbo

DNA nanoflower Oligo-PROTAC for targeted degradation of FUS to treat neurodegenerative diseases.

DNA纳米花Oligo-PROTAC用于靶向降解FUS以治疗神经退行性疾病

Ge Ruixin, Chen Miao, Wu Sijin, Huang Sirui, Zhou Ping, Cao Minghui, Zhang Fan, Zang Jinzhi, Zhu Yigao, Li Jingrui, Ni Guilin, Yang Zhihao, Li Qingchao, Pan Wei, Zhang Liang, Liu Min, Xuan Chenghao, Yu Haiyang, Zhou Jun, Xie Songbo

Selective degradation of the p53-R175H oncogenic hotspot mutant by an RNA aptamer-based PROTAC

利用基于RNA适配体的PROTAC选择性降解p53-R175H致癌热点突变体

Kong, Lingping; Meng, Fanlu; Wu, Sijin; Zhou, Ping; Ge, Ruixin; Liu, Min; Zhang, Linlin; Zhou, Jun; Zhong, Diansheng; Xie, Songbo

HDAC6 regulates antibody-dependent intracellular neutralization of viruses via deacetylation of TRIM21

HDAC6 通过对 TRIM21 进行去乙酰化来调节抗体依赖性细胞内病毒中和作用。

Xie, Songbo; Zhang, Linlin; Dong, Dan; Ge, Ruixin; He, Qianqian; Fan, Cunxian; Xie, Wei; Zhou, Jun; Li, Dengwen; Liu, Min